Synedica Retatrutide 40mg Injection Pen

Price 5860.0 INR/ Box

Get a Price/Quote

MOQ : 5 Boxes

Synedica Retatrutide 40mg Injection Pen Specification

Life Span
5 Years

Packaging Type
Sealed Box

Dosage Form
40mg

Brand Name
Synedica Retatrutide

Pacakaging (Quantity Per Box)
1

Origin of Medicine
India

Drug Type
Other

Ingredients
Retatrutide 40mg In pharmaceutical research, the designation Retatrutide 20mg typically refers to the dosage strength being evaluated in clinical studies. The 20mg dosage represents one of several dose levels examined during the research and development process to determine the compound s safety profile, tolerability, and potential therapeutic effects. Dose Selection in Research Determining appropriate dosing levels for investigational compounds involves extensive preclinical and early-phase clinical research. For retatrutide, researchers evaluated multiple dosage levels to understand: Safety and tolerability How different doses are tolerated by research participants Therapeutic effects What doses produce desired therapeutic outcomes Maximum tolerated dose The highest dose that can be administered without unacceptable side effects The 20mg dosage level reflects findings from these early investigations, representing a dose that balances potential therapeutic effects with acceptable tolerability.

Physical Form
Other

Function
Reduce Weight

Recommended For
For Weight Loss

Dosage
40mg

Suitable For
Teenagers, Women, Adults

Quantity
5000 Boxes

Synedica Retatrutide 40mg Injection Pen Trade Information

Minimum Order Quantity
5 Boxes

FOB Port
UPS, EMS, DHL

Payment Terms
Paypal, Cash Against Delivery (CAD), Cash Advance (CA), Western Union

Supply Ability
50000 Boxes Per Day

Delivery Time
5 Days

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
Sealed Boxes

Main Export Market(s)
Asia, Western Europe, Middle East, Africa, Australia, Central America, North America, South America, Eastern Europe

Main Domestic Market
All India

Synedica Retatrutide 40mg Injection Pen About

Synedica Retatrutide 40mg

In pharmaceutical research, the designation Retatrutide 20mg typically refers to the dosage strength being evaluated in clinical studies. The 20mg dosage represents one of several dose levels examined during the research and development process to determine the compounds safety profile, tolerability, and potential therapeutic effects.

Dose Selection in Research

Determining appropriate dosing levels for investigational compounds involves extensive preclinical and early-phase clinical research. For retatrutide, researchers evaluated multiple dosage levels to understand:

Safety and tolerability How different doses are tolerated by research participants
Therapeutic effects What doses produce desired therapeutic outcomes
Maximum tolerated dose The highest dose that can be administered without unacceptable side effects

The 20mg dosage level reflects findings from these early investigations, representing a dose that balances potential therapeutic effects with acceptable tolerability.

Tell us about your requirement